4422
D. P. Curran et al. / Tetrahedron 60 (2004) 4413–4424
2H), 7.02 (s, 1H), 7.07–7.12 (m, 2H), 7.18–7.30 (m, 8H),
7.64 (s, 1H); 13C NMR (75 MHz, CDCl3) d 19.3, 20.4, 41.3,
51.3, 101.3, 124.1, 126.3, 126.6, 127.5, 128.1, 128.4, 129.5,
132.2, 133.4, 134.4, 136.5, 138.1, 138.3, 140.0, 140.1,
170.6; HRMS (EI) calcd for C25H24INO 481.0903, found
481.0927; LRMS (EI) m/z 481 (Mþ, 58), 390 (44), 363 (8),
236 (27), 158 (21), 117 (100), 91 (84). The racemate was
submitted to preparative chiral HPLC separation (Regis
Technologies (S,S)-Whelk-O1; 25 cm£10.0 mm I.D.;
10 mL/min hexanes:iPrOH; first eluting enantiomer (P)
a2D3 217, 94% ee (c 6.3 mg/mL, CHCl3); second eluting
enantiomer (M) a2D3 þ11, 98% ee (c 9.9 mg/mL, CHCl3).
7.6 Hz, 1H), 4.54 (dd, J¼14.3, 6.5 Hz, 1H), 5.04–5.15 (m,
2H), 5.97 (dddd, J¼6.5, 7.5, 9.8, 13.7 Hz, 1H), 7.02 (s, 1H),
7.10–7.20 (m, 3H), 7.23 (d, J¼6.7 Hz, 2H), 7.58 (s, 1H);
13C NMR (75 MHz, CDCl3) d 19.4, 20.4, 31.2, 36.3, 51.6,
101.4, 118.7, 125.9, 128.3, 128.5, 132.1, 132.9, 137.7,
138.3, 139.9, 140.1, 141.4, 171.8; HRMS (EI) calcd for
C20H22INO 419.0746, found 419.0743; LRMS (EI) m/z 419
(Mþ, 32), 292 (100), 160 (37), 158 (32), 155 (25), 131 (34),
105 (59). The racemate was submitted to preparative chiral
HPLC separation (Regis Technologies (S,S)-Whelk-O1;
25 cm£10.0 mm I.D.; 10 mL/min hexanes:iPrOH; first
eluting enantiomer (P) a2D3 260, 99% ee (c 3.8 mg/mL,
CHCl3); second eluting enantiomer (M) a2D3 þ58, 99% ee (c
4.3 mg/mL, CHCl3).
4.4.13. rac-N-But-2E-enyl-N-(2-iodo-4,6-dimethyl-
phenyl)-2-phenylacetamide (17e). This compound was
prepared according to general procedure II. A clear, yellow
oil was obtained in 41% yield. IR (thin film, CHCl3, NaCl,
cm21) 3012, 2921, 2856, 1650, 1496, 1465, 1455, 1393,
1313, 1262, 1247, 1165, 970; 1H NMR (300 MHz, CDCl3) d
1.59 (d, J¼5.9 Hz, 3H), 2.04 (s, 3H), 2.33 (s, 3H), 3.20 (d,
J¼15.0 Hz, 1H), 3.39 (d, J¼15.0 Hz, 1H), 3.94 (dd, J¼14.0,
7.1 Hz, 1H), 4.38 (dd, J¼14.0, 6.3 Hz, 1H), 5.53 (m, 2H),
7.03 (s, 1H), 7.08 (m, 2H), 7.22 (m, 3H), 7.63 (s, 1H); 13C
NMR (75 MHz, CDCl3) d 17.5, 19.2, 20.3, 41.4, 50.9,
101.9, 125.5, 126.5, 128.0, 129.1, 129.5, 129.9, 132.0,
134.6, 138.2, 139.8, 140.3, 170.4; HRMS (EI) calcd for
C20H22INO 419.0746, found 419.0737; LRMS (EI) m/z 419
(Mþ, 55), 292 (44), 238 (37), 174 (30), 158 (33), 91 (98),
55(100). The racemate was submitted to preparative chiral
HPLC separation (Regis Technologies (S,S)-Whelk-O1;
25 cm£10.0 mm I.D.; 10 mL/min hexanes:iPrOH; first
eluting enantiomer (P) a2D3 246, 99% ee (c 4.7 mg/mL,
CHCl3); second eluting enantiomer (M) a2D3 þ41, 99% ee (c
11.4 mg/mL, CHCl3).
4.4.16. rac-N-Allyl-N-(2-iodo-4,6-dimethylphenyl)-trans-
crotonamide (17h). This compound was prepared accord-
ing to general procedure I. A white, crystalline solid was
obtained in 64% yield. IR (thin film, CH2Cl2, NaCl, cm21
)
2984, 2854, 1666, 1629, 1445, 1384, 1273; 1H NMR
(300 MHz, CDCl3) d 1.73 (dd, J¼6.9, 1.5 Hz, 3H), 2.18 (s,
3H), 2.31 (s, 3H), 3.94 (ddd, J¼14.3, 7.1, 0.6 Hz, 1H), 4.58
(dd, J¼14.3, 6.4 Hz, 1H), 5.02–5.11 (m, 2H), 5.48 (dd, J¼
15.0, 1.7 Hz, 1H), 5.97 (dddd, J¼17.0, 10.0, 7.7, 6.5 Hz,
1H), 7.00 (dq, J¼15.0, 6.9 Hz, 1H), 7.04 (s, 1H), 7.60 (s,
1H); 13C NMR (75 MHz, CDCl3) d 18.0, 19.7, 20.5 51.6,
101.6, 118.7, 121.9, 125.4, 132.0, 133.1, 138.2, 138.8,
139.9, 140.0, 142.4, 165.8; HRMS (EI) calcd for
C15H18INO 355.0433, found 355.0445; LRMS (EI) m/z
355 (Mþ, 25), 340 (20), 313 (13), 287 (16), 228 (100), 18
(39), 158 (32), 69 (68).
4.4.17. rac-N-(2-Iodo-4,6-dimethylphenyl)-N-(3-methyl-
but-2E-enyl)acetamide (17i). This compound was pre-
pared according to general procedure I. An orange-yellow
oil was obtained in 84% yield. IR (thin film, CHCl3, NaCl,
cm21) 3005, 2926, 2858, 1643, 1553, 1467, 1440, 1396,
4.4.14. rac-N-(2-Iodo-4,6-dimethylphenyl)-N-(3-methyl-
but-2-enyl)-2-phenylacetamide (17f). This compound was
prepared according to general procedure II. A clear, yellow
oil was obtained in 79% yield. IR (thin film, CHCl3, NaCl,
cm21) 3026, 3014, 2925, 2861, 1650, 1495, 1455, 1383,
1236, 1186, 1162, 1032; 1H NMR (300 MHz, CDCl3) d 1.43
(s, 3H), 1.62 (s, 3H), 2.03 (s, 3H), 2.43 (s, 3H), 3.21 (d,
J¼15.0 Hz, 1H), 3.39 (d, J¼15.0 Hz, 1H), 4.04 (dd, J¼14.3,
8.0 Hz, 1H), 4.45 (dd, J¼14.3, 7.1 Hz, 1H), 5.03 (dd, J¼7.0,
7.0 Hz, 1H), 7.03 (s, 1H), 7.18 (m, 5H), 7.62 (s, 1H); 13C
NMR (75 MHz, CDCl3) d 17.4, 19.0, 20.3, 25.5, 41.1, 45.9,
53.8, 101.7, 118.7, 126.4, 127.9, 129.4, 131.9, 134.5, 136.2,
138.1, 139.7, 140.0, 170.4; HRMS (EI) calcd for
C21H24INO 433.0903, found 433.0901; LRMS (EI) m/z
433 (Mþ, 100), 390 (9), 365 (27), 300 (21), 273 (14), 247
(17), 238 (41), 91 (93), 69 (66). The racemate was
submitted to preparative chiral HPLC separation (Regis
Technologies (S,S)-Whelk-O1; 25 cm£10.0 mm I.D.;
10 mL/min hexanes:iPrOH; first eluting enantiomer (P)
a2D3 249, 99% ee (c 2.2 mg/mL, CHCl3); second eluting
enantiomer (M) a2D3 þ43, 99% ee (c 4.5 mg/mL, CHCl3).
1
1289, 1034, 908; H NMR (300 MHz, CDCl3) d 1.42 (s,
3H), 1.62 (s, 3H), 1.74 (s, 3H), 2.20 (s, 3H), 2.28 (s, 3H),
3.94 (dd, J¼14.5, 8.2 Hz, 1H), 4.50 (dd, J¼14.5, 7.1 Hz,
1H), 5.26 (m, 1H), 7.03 (s, 1H), 7.57 (s, 1H); 13C NMR
(75 MHz, CDCl3) d 17.6, 19.4, 20.5, 22.4, 25.7, 45.6, 101.2,
118.9, 132.0, 136.4, 137.9, 138.3, 139.8, 140.9, 170.3;
HRMS (EI) calcd for C15H20INO 357.0590, found
357.0603; LRMS (EI) m/z 357 (Mþ, 95), 314 (37), 300 (46),
289 (83), 247 (56), 232 (46), 162 (87), 69 (100).
4.4.18. Phenyl-(3,5,7-trimethyl-2,3-dihydroindol-1-
yl)methanone (18a). This compound was prepared accord-
ing to general procedure IV. The atropisomer M-17a
(.99% ee, second eluting enantiomer) yielded a white,
crystalline solid in 92% yield (87% ee, 23, second eluting
enantiomer). The atropisomer P-17a (99% ee, first eluting
enantioimer) yielded a white, crystalline solid in 95% yield
(86% ee, þ3, first eluting enantiomer). A racemic standard
of the title compound was prepared in 98% yield by radical
cyclization of rac-17a according to general procedure III.
IR (thin film, CH2Cl2, NaCl, cm21) 2966, 1649, 1371, 1264;
1H NMR (300 MHz, CDCl3) d 1.24 (d, J¼7.0 Hz, 3H), 2.20
(s, 3H), 2.34 (s, 3H), 3.33 (sex, J¼7.3 Hz, 1H), 3.65 (dd,
J¼10.4, 7.6 Hz, 1H), 4.22 (dd, J¼10.4, 7.7 Hz, 1H), 6.88 (s,
1H), 6.91 (s, 1H), 7.40–7.55 (m, 3H), 7.74 (d, J¼6.7 Hz,
2H); 13C NMR (75 MHz, CDCl3) d 17.8, 19.9, 21.1, 36.9,
4.4.15. rac-N-Allyl-N-(2-iodo-4,6-dimethylphenyl)-3-
phenylpropionamide (17g). This compound was prepared
according to general procedure II. A clear, yellow oil was
obtained in 97% yield. IR (thin film, CHCl3, NaCl, cm21
2926, 1649, 1395; H NMR (300 MHz, CDCl3) d 2.12 (s,
3H), 2.28 (s, 3H), 2.95–3.05 (m, 2H), 3.96 (dd, J¼14.3,
)
1